- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Benzquinamide is a drug used to treat gastrointestinal disorders. It is a quinolone derivative, and is used to treat a variety of gastrointestinal conditions, including irritable bowel syndrome, ulcerative colitis, and Crohn's disease. It is also used to treat nausea and vomiting associated with chemotherapy. Benzquinamide works by inhibiting the growth of bacteria in the gastrointestinal tract, reducing inflammation, and relieving symptoms.
Benzquinamide is available in both oral and injectable forms, and is generally well tolerated. Common side effects include nausea, vomiting, and diarrhea. Serious side effects are rare, but can include allergic reactions, liver damage, and kidney damage.
The benzquinamide market is a small but growing segment of the gastrointestinal drugs market. It is used to treat a variety of gastrointestinal conditions, and is generally well tolerated.
Some companies in the benzquinamide market include Pfizer, Merck, and Novartis. Show Less Read more